Is long-acting repeatable octreotide an effective primary therapy for patients with acromegaly?

被引：0
|
作者：
Vivien S Bonert
机构：
[1] David Geffen School of Medicine,VS Bonert is a Professor in the Department of Medicine at Cedars Sinai Medical Center
[2] University of California,undefined
[3] Los Angeles,undefined
[4] CA,undefined
[5] USA.,undefined
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：18 / 19
页数：1
相关论文
共 50 条
  • [41] OCTREOTIDE - A LONG-ACTING SOMATOSTATIN ANALOG
    BROWN, NJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1990, 300 (04): : 267 - 273
  • [42] Long-term therapy with long-acting octreotide (Sandostatin-LAR®) for the management of acromegaly (vol 48, pg 311, 1998)
    Davies, PH
    Stewart, SE
    Lancranjan, I
    Sheppard, MC
    Stewart, PM
    CLINICAL ENDOCRINOLOGY, 1998, 48 (05) : 673 - 673
  • [43] Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension
    Cui, Pei-Jing
    Yao, Jing
    Zhu, Yin
    Zhang, Zheng-Yun
    Yang, Jun
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
  • [44] Diabetic ketoacidosis in a patient with acromegaly and central diabetes insipidus treated with octreotide long-acting release
    Inaba H.
    Funahashi T.
    Ariyasu H.
    Iwakura H.
    Furuta H.
    Nishi M.
    Akamizu T.
    Diabetology International, 2017, 8 (2) : 237 - 242
  • [45] IMPACT OF OCTREOTIDE, A LONG-ACTING SOMATOSTATIN ANALOG, ON GLUCOSE-TOLERANCE AND INSULIN SENSITIVITY IN ACROMEGALY
    HO, KKY
    JENKINS, AB
    FURLER, SM
    BORKMAN, M
    CHISHOLM, DJ
    CLINICAL ENDOCRINOLOGY, 1992, 36 (03) : 271 - 279
  • [46] NO EFFECT OF THE LONG-ACTING SOMATOSTATIN ANALOG OCTREOTIDE IN PATIENTS WITH INSULINOMA
    TIMMER, R
    KONINGSBERGER, JC
    ERKELENS, DW
    THIJSSEN, JHH
    LIPS, CJM
    KOPPESCHAAR, HPF
    NETHERLANDS JOURNAL OF MEDICINE, 1991, 38 (5-6): : 199 - 203
  • [47] Serial follow-up of presurgical treatment using pasireotide long-acting release with or without octreotide long-acting release for naive active acromegaly
    Chang, Jan-Shun
    Tseng, Ham-Min
    Chang, Tien-Chun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (06) : 475 - 480
  • [48] Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients With Neuroendocrine Tumors An ITMO Group Study
    Bajetta, Emilio
    Catena, Laura
    Fazio, Nicola
    Pusceddu, Sara
    Biondani, Pamela
    Blanco, Giusi
    Ricci, Sergio
    Aieta, Michele
    Pucci, Francesca
    Valente, Monica
    Bianco, Nadia
    Mauri, Chiara Maria
    Spada, Francesca
    CANCER, 2014, 120 (16) : 2457 - 2463
  • [49] Long-acting somatostatin analog therapy of acromegaly: A meta- analysis
    Freda, PU
    Katznelson, L
    van der Lely, AJ
    Reyes, CM
    Zhao, SH
    Rabinowitz, D
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08): : 4465 - 4473
  • [50] Octreotide Long-Acting Release (LAR)A Review of its Pharmacological Properties and Therapeutic Use in the Management of Acromegaly
    Jane C. Gillis
    Stuart Noble
    Karen L. Goa
    Drugs, 1997, 53 : 681 - 699
12345